CRP and neoplasm: Our study had some limitations, including the exclusion of hospital-acquired sepsis;analysis of a single biomarker (C-reactive protein), while other biomarkers or biomarkerpanels (procalcitonin and cytokines) were excluded; absence of microbiologicaldocumentation for approximately 40% of the patients; and non-inclusion of the full rangeof neoplastic diseases, as neoplasm was defined only as a metastatic disease.